Agrreed buc. And i personally believe that if CLSN pulls up as hard as i think it will, that there will be a short term impact to ctix pricing to follow.

The thing ive noticed is the smartest minds all seem to end up on the same forums following, lurking, and strategizing on a few of the same compelling biotechs. I think many more risk averse investors are well aware of the potential of ctix, but feel much more comfortable loading up on CLSN as it is further along in trials.

I think it could work out favorably for ctix longs that when CLSN profits are realized a ways down the road, we will see a steady influx of upward buying pressure as a good chunk of those investors build positions in ctix. Hell, bio alone can move the market for a day if he jumps in, what happens when "big" money from CLSN comes this way? (I mean big from an individual perspective, not from institutional interest)

I do agree with drano and jeff that from an end game perspective, this will have minimal impact, as the drugs will be valuated based on trail results, but i certainly wont complain about some help from the CLSN crew as i am anxious to see us up on the nasdaq ASAP. The CLSN effect can possibly help us get there a bit sooner. Or not.